Le Lézard
Classified in: Health, Business
Subject: PER

Don Casey Joins Avista Capital Partners as a Strategic Executive


NEW YORK, April 1, 2024 /PRNewswire/ -- Avista Capital Partners ("Avista"), a leading New York-based private equity firm focused exclusively on healthcare, today announced that Don Casey has joined the firm as a Strategic Executive. Mr. Casey most recently served as the Chief Executive Officer of Dentsply Sirona, the world's largest manufacturer of professional dental products and technologies.

Mr. Casey has more than 30 years of global healthcare experience and an outstanding track record of identifying and commercializing successful medical innovations. Prior to Dentsply, he served as Chief Executive Officer of the Medical segment of Cardinal Health, a leading provider of medical products and supply chain services to sites of care across the health care continuum. In this role, Mr. Casey delivered consistent revenue and operating income growth as well as meaningful margin expansion and helped position the segment for sustainable future growth. Prior to Cardinal Health, Mr. Casey served as Chief Executive Officer of the Gary and Mary West Wireless Health Institute, and previously as worldwide chairman for Johnson & Johnson's comprehensive care group and a member of the company's executive committee.

Avista's Strategic Executive Group is comprised of healthcare industry leaders from blue-chip companies within Avista's targeted healthcare sub-sectors and is a strong differentiator for the firm. Strategic Executives are an integral part of Avista's investment process and are deeply involved across each step of the investment lifecycle. Mr. Casey will support Avista's efforts in a variety of sub-sectors including medical technology and specialty distribution.

David Burgstahler, Managing Partner and Chief Executive Officer of Avista Capital Partners, said, "It is a pleasure to welcome Don, who brings invaluable insights across Avista's product and technology healthcare focus that will further fortify our ability to drive transformative growth and innovation within the healthcare sector. In particular, Don's broad expertise and strategic insight will be key in shaping our future successes as we pursue attractive investment opportunities across our core sub-sectors."

Don Casey, Strategic Executive at Avista Capital Partners said, "I have long admired Avista Capital and their outstanding reputation in the healthcare space. I am eager to contribute to their strategy of growing and developing outstanding healthcare companies, and I am thrilled to be working alongside their talented team."

About Avista Capital Partners

Founded in 2005, Avista Capital is a leading New York-based private equity firm with over $8 billion invested in more than 45 growth-oriented healthcare businesses globally. Avista partners with businesses that feature strong management teams, stable cash flows and robust growth prospects ? targeting healthcare product and technology businesses with clear scale potential across six sub-sectors experiencing strong tailwinds. The team is supported by a group of seasoned Strategic Executives enhancing the entire investment process through strategic insight, operational oversight and senior counsel, which helps drive growth and performance, while fostering sustainable businesses and creating long-term value for all stakeholders. For more information, visit www.avistacap.com.

Media contact:
Daniel Yunger / Hallie Wolff
Kekst CNC
[email protected] / [email protected]

SOURCE Avista Capital Partners


These press releases may also interest you

at 08:35
Silence Therapeutics plc, Nasdaq: SLN ("Silence" or "the Company"), an experienced and innovative biotechnology company committed to transforming people's lives by silencing diseases through precision engineered medicines, today reported its...

at 08:32
Moleculin Biotech, Inc., ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses, today announced its abstract has been accepted for poster...

at 08:32
In a complex medical environment, seriously ill patients and family members need support navigating the healthcare system and deciding on the best courses of treatment. VitalTalk was developed to ensure that every patient is cared for by clinicians...

at 08:30
Assure Holdings Corp. (the "Company" or "Assure") , a provider of intraoperative neuromonitoring ("IONM") and remote neurology services, announced today that at its adjourned Special Shareholder Meeting held on May 14, 2024, shareholders approved the...

at 08:30
FastWave Medical, a clinical-stage medical device company developing advanced intravascular lithotripsy (IVL) technology, achieves a significant milestone with the issuance of its fifth utility patent by the United States Patent and Trademark Office...

at 08:30
In this free webinar, learn why traditional methods employed in observational studies and registries are rapidly becoming obsolete in today's dynamic healthcare environment. Attendees will gain insights into the increasing demand for greater...



News published on and distributed by: